A robust, trial-agnostic gene signature for response to tyrosine kinase inhibition in ccRRCC Meeting Abstract


Authors: Khaleel, S. S.; Liu, M.; Kuo, F.; Kotecha, R.; Lee, C. H.; Voss, M. H.; Motzer, R. J.; Hakimi, A. A.; Reznik, E.
Abstract Title: A robust, trial-agnostic gene signature for response to tyrosine kinase inhibition in ccRRCC
Meeting Title: 2022 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 16 Suppl.
Meeting Dates: 2022 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-06-01
Language: English
ACCESSION: WOS:000863680301378
PROVIDER: wos
DOI: 10.1200/JCO.2022.40.16_suppl.4558
Notes: Meeting Abstract: 4558 -- Meeting also held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Robert Motzer
    1248 Motzer
  2. Martin Henner Voss
    294 Voss
  3. Abraham Ari Hakimi
    327 Hakimi
  4. Eduard Reznik
    108 Reznik
  5. Chung-Han   Lee
    157 Lee
  6. Fengshen Kuo
    81 Kuo
  7. Minwei Liu
    24 Liu
  8. Ritesh Rajesh Kotecha
    94 Kotecha
  9. Sari Khaleel
    14 Khaleel